Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.

Saved in:
Bibliographic Details
Title: Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Authors: Shiga T; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan., Nozaki Y; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan., Tomita D; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan., Kishimoto K; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan., Hirooka Y; Department of Rheumatology, Kindai University Nara Hospital, Nara, Japan., Kinoshita K; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan., Funauchi M; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan., Matsumura I; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
Source: Frontiers in immunology [Front Immunol] 2021 Oct 08; Vol. 12, pp. 750114. Date of Electronic Publication: 2021 Oct 08 (Print Publication: 2021).
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2021.750114